Provided by Tiger Trade Technology Pte. Ltd.

NEUROONE MEDICAL TECH

1.77
-0.2100-10.61%
Post-market: 1.68-0.0900-5.08%19:59 EDT
Volume:519.44K
Turnover:953.88K
Market Cap:16.12M
PE:-1.85
High:1.96
Open:1.89
Low:1.70
Close:1.98
52wk High:6.96
52wk Low:1.42
Shares:9.11M
Float Shares:6.27M
Volume Ratio:0.18
T/O Rate:8.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9571
EPS(LYR):-0.5387
ROE:-124.66%
ROA:-58.07%
PB:4.28
PE(LYR):-3.29

Loading ...

NeuroOne Medical Technologies Corp expected to post a loss of 23 cents a share - Earnings Preview

Reuters
·
May 08

NeuroOne regains Nasdaq compliance after shares hold above $1 bid price

Reuters
·
May 04

NeuroOne COO Christopher Volker to become CFO as McClurg retires

Reuters
·
Apr 30

Neuroone Medical Technologies Corp - Ronald Mcclurg to Retire as CFO Effective June 30, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 30

U.S. RESEARCH ROUNDUP-Coca-Cola Co, Mondelez, Zeta Global Holdings

Reuters
·
Apr 29

Neuroone Medical Technologies Corp : Jonestrading Adjusts Target Price to $8 From $1.5 to Reflect 1-for-6 Reverse Stock Split

THOMSON REUTERS
·
Apr 29

NeuroOne Medical Technologies trading halted, news pending

TIPRANKS
·
Apr 16

NASDAQ TRADE HALT HALT NEWS PENDING AT 07:50 PM

Reuters
·
Apr 16

Neuroone Medical Technologies Corp - Approves 1-for-6 Reverse Stock Split Effective April 15, 2026 - SEC Filing

THOMSON REUTERS
·
Apr 14

NeuroOne shareholders approved reverse stock split amendment, elected two directors

Reuters
·
Apr 04

NeuroOne Business Development Director Mark Christianson sells USD 0.01 million common shares

Reuters
·
Apr 02

NeuroOne Business Development Director Mark Christianson Disposes of USD 734 in Common Shares

Reuters
·
Mar 17

Boston Scientific Corp Stock Moved Down by 3.32% on Mar 3: Facts Behind the Movement

TradingKey
·
Mar 04

NeuroOne Medical Technologies Files Initial Beneficial Ownership Statement for Chief Business Officer David J. Wambeke

Reuters
·
Mar 03

NeuroOne Medical Tech Initiated at Buy by Jones Trading

Dow Jones
·
Mar 02